بررسی بیان ژن‌های PIN1، β-catenin و cyclin D1 در بافت توموری افراد مبتلا به سرطان کولورکتال

Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 2021;325:669-85. doi:10.1001/jama.2021.0106

Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers 2022;14. doi:10.3390/cancers14071732

Murphy N, Moreno V, Hughes DJ, Vodicka L, Vodicka P, Aglago EK, et al. Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Molecular Aspects of Medicine 2019;69:2-9. doi: 10.1016/j.mam.2019.06.005

Gholamzadeh Khoei S, Saidijam M, Amini R, Jalali A, Najafi R. Impact of PIN1 inhibition on tumor progression and chemotherapy sensitivity in colorectal cancer. Journal of Gastrointestinal Cancer 2022;1-12. doi: 10.1007/s12029-021-00600-6

Kim G, Bhattarai PY, Choi HS. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer. Archives of Pharmacal Research 2019;42:128-39. doi: 10.1007/s12272-019-01122-3

Cheng C-W, Tse E. PIN1 in cell cycle control and cancer. Frontiers in Pharmacology 2018;9:1367. doi: 10.3389/fphar.2018.01367

Kim CJ, Cho YG, Park YG, Nam SW, Kim SY, Lee SH, et al. Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression. World Journal of Gastroenterology 2005;11:5006-9. doi: 10.3748/wjg.v11.i32.5006

Stewart R, Sharma S, Wu T, Okuda S, Xie G, Zhou XZ, et al. The role of the master cancer regulator Pin1 in the development and treatment of cancer. Frontiers in cell and Developmental Biology 2024;12:1343938. doi: 10.3389/fcell.2024.1343938

The investigation of the role of Fas and FasL molecules in the extrinsic pathway of apoptosis as a target for cancer therapy in colorectal cancer. Clin Exc 2020;10:1-17.[Persian].

Jun SY, Kim J, Yoon N, Maeng LS, Byun JH. Prognostic potential of cyclin d1 expression in colorectal cancer. Journal of Clinical Medicine 2023;12. doi: 10.3390/jcm12020572

Mosaad H, Ahmed MM, Elaidy MM, Elfarargy OM, Abdelwahab MM, Abdelnour HM. Down-regulated MiRNA 29-b as a diagnostic marker in colorectal cancer and its correlation with ETV4 and Cyclin D1 immunohistochemical expression. Cancer Biomarkers: Section A of Disease Markers 2023;37:179-89. doi: 10.3233/CBM-220349

Rosen R, Sapra A. TNM Classification. StatPearls. Treasure Island (FL). Stat Pearls Publishing Copyright;2020.

Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H, Sugihara K. High Pin1 expression is associated with tumor progression in colorectal cancer. Journal of Surgical Oncology 2006;94:155-60. doi: 10.1002/jso.20510

Wu W, Xue X, Chen Y, Zheng N, Wang J. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies. Pharmacological Research 2022;184:106456. doi: 10.1016/j.phrs.2022.106456

Gholamzadeh Khoei S, Saidijam M, Amini R, Jalali A, Najafi R. Impact of PIN1 inhibition on tumor progression and chemotherapy sensitivity in colorectal cancer. J Gastrointest Cancer 2022;53:299-310. doi: 10.1007/s12029-021-00600-6

Chen Y, Wu YR, Yang HY, Li XZ, Jie MM, Hu CJ, et al. Prolyl isomerase Pin1: a promoter of cancer and a target for therapy. Cell Death & Disease 2018;9:883. doi: 10.1038/s41419-018-0844-y

Yu JH, Im CY, Min SH. Function of PIN1 in cancer development and its inhibitors as cancer therapeutics. Frontiers in Cell and Developmental Biology 2020;8:120. doi: 10.3389/fcell.2020.00120

Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, et al. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Research 2003;63:6244-51.

Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduction and Targeted Therapy 2022;7:3. doi: 10.1038/s41392-021-00762-6

Fuchs SY, Ougolkov AV, Spiegelman VS, Minamoto T. Review oncogenic β-catenin signaling networks in colorectal cancer. Cell Cycle 2005;4:1522-39.

Fodde R. The APC gene in colorectal cancer. European Journal of Cancer 2002;38:867-71. doi: 10.1016/S0959-8049(02)00040-0

Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Molecular Cancer 2022;21:144. doi: 10.1186/s12943-022-01616-7

Wanitsuwan W, Kanngurn S, Boonpipattanapong T, Sangthong R, Sangkhathat S. Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers. World Journal of Gastroenterology 2008;14:6052-9. doi: 10.3748/wjg.14.6052

Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, et al. Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology 2001;61:226-33. doi: 10.1159/000055379

Bian J, Dannappel M, Wan C, Firestein R. Transcriptional regulation of wnt/β-catenin pathway in colorectal cancer. Cells 2020;9. doi: 10.3390/cells9092125